Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Regulation of immune response to virus and aeroallergen by infant gut microbial products: mechanistic studies

Award Number: R01AI201440
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2026
PERIOD OF PERFORMANCE END DATE: 07/31/2031

Group Awards By:

View Award Description

Regulation of immune response to virus and aeroallergen by infant gut microbial products: mechanistic studies - Our group recently identified a real-life model that uniquely illustrates the impact of the environment on asthma risk. Two populations of comparable Mexican ancestry living only 70 miles apart in Tucson, AZ, USA and Nogales, Mexico (MX) differ strikingly in their rates of childhood asthma, which are 4-fold lower in MX. The Binational Early Asthma and Microbiome Study (BEAMS-1, P01AI148104) was launched to test the hypothesis that MX or US residence impacts microbiome composition and metabolic capacity in pregnant mothers and their children, thereby shaping microbiome and immune responses and the child’s asthma risk. Initial findings from BEAMS-1 have supported this hypothesis. Asthma-predictive symptom (S) scores at 6-9 months (mo) were significantly higher in US than MX infants and were significantly associated with infant fecal microbiome composition and metabolome. Dietary lipids were the largest class of S-score-associated stool metabolites. Oleic, palmitic & linoleic acid metabolites were enriched in high S-score infants, while poly- unsaturated fatty acids were enriched in low S-score infants. These data linked dietary lipid stool metabolites to S-scores and infant asthma risk, but the underlying mechanisms remained unknown. Because asthma risk is associated with both early allergic sensitization and early respiratory viral infections, we now propose to define the mechanisms through which stool metabolites from BEAMS children with distinct S-scores differentially affect immune responses to airway viral infection and aeroallergens, and airway barrier integrity. Our plan stems from a rich set of preliminary data. Sterile fecal extracts (SFEs) from 1-mo-old infants with distinct S-scores 1) differed in their ability to reduce viral load and promote anti-viral responses in mice infected with human rhinovirus (RV), and 2) differentially affected aeroallergen-driven lung inflammation, in part through a novel B cell/IL17/neutrophil pro-inflammatory axis. 3) SFEs from 1-mo old MX infants more effectively promoted human airway epithelial barrier integrity compared to SFEs from their US counterparts. 4) Specific stool metabolites enriched in asthma-protected farm children protected mice from allergic inflammation and enhanced human airway barrier integrity. Therefore, we hypothesize that increased infant S-scores reflect the production of pathogenic microbial metabolites that dysregulate immune responses to respiratory viruses and aeroallergens, and impair airway barrier integrity, thus licensing the initiation of the asthma trajectory. Relying on extant BEAMS samples, we propose to expose mice to SFEs from 1- and 24-mo children with distinct S-scores and characterize the immune mechanisms and microbial metabolites that dysregulate responses to RV infection (Aim 1) and aeroallergen (Aim 2). (Aim 3) will characterize the transcriptional mechanisms that regulate human airway barrier responses to 1- and 24-mo SFEs from children with distinct S- scores, and their relation to SFEs metabolites. Our data will reveal mechanisms that connect gut microbial metabolites to asthma-predictive symptoms and inform approaches that target microbial metabolic dysfunction.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $797,394 )
2026	2026	UNIVERSITY OF ARIZONA	845 N PARK AVE RM 538	TUCSON	AZ	85721	PIMA	USA	Allergy and Infectious Diseases Research	000	1	8/1/2026	NEW	$797,394
														Subtotal = $797,394

Grand Total All Awards = $797,394

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Regulation of immune response to virus and aeroallergen by infant gut microbial products: mechanistic studies

Award Number: R01AI201440

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2026

PERIOD OF PERFORMANCE END DATE: 07/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer